Occudo Quantitative Strategies’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-17,682
Closed -$879K 611
2025
Q1
$879K Buy
17,682
+8,811
+99% +$557K 0.12% 257
2024
Q4
$620K Buy
+8,871
New +$737K 0.11% 261
2024
Q1
Sell
-3,826
Closed -$496K 707
2023
Q4
$496K Buy
+3,826
New +$527K 0.07% 402
2023
Q2
Sell
-1,506
Closed -$201K 979
2023
Q1
$201K Sell
1,506
-8,890
-86% -$1.04M 0.02% 754
2022
Q4
$825K Buy
10,396
+1,887
+22% +$133K 0.1% 340
2022
Q3
$515K Buy
8,509
+1,808
+27% +$117K 0.04% 651
2022
Q2
$367K Sell
6,701
-189
-3% -$11K 0.03% 722
2022
Q1
$520K Sell
6,890
-1,196
-15% -$81.7K 0.04% 634
2021
Q4
$603K Buy
8,086
+2,553
+46% +$151K 0.05% 554
2021
Q3
$260K Buy
+5,533
New +$241K 0.03% 779

Other funds holding ACLS

Occudo Quantitative Strategies's ACLS Position: Q2 2025 in Review

Occudo Quantitative Strategies sold out of Axcelis (ACLS) in Q2 2025, closing a stake of 17,682 shares — an estimated $879K sold.

Occudo Quantitative Strategies first reported a position in ACLS in Q3 2021 and held it in 10 quarters. The position peaked at $879K in Q1 2025. 328 funds tracked by Wall St. Rank hold ACLS as of Q2 2025.

  • Occudo Quantitative Strategies reported no remaining Axcelis position as of Q2 2025 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 17,682 Axcelis shares in Q2 2025, an estimated $879K.
  • Occudo Quantitative Strategies first reported a position in Axcelis in Q3 2021 and held it in 10 quarters.
  • Occudo Quantitative Strategies's Axcelis position peaked at $879K in Q1 2025.
  • 328 funds tracked by Wall St. Rank held Axcelis as of Q2 2025.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.